Tryptamine Therapeutics Limited
TYPTF
$0.01
$0.00-6.67%
OTC PK
| 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 508.64% | 16.81% | 16.81% | 650.21% | 146.84% |
| Total Receivables | 6,654.90% | 2,342.02% | 2,342.02% | 4,380.28% | 561.11% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1,144.33% | 1,141.64% | 1,141.64% | 833.17% | -79.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -58.71% |
| Total Current Assets | 909.12% | 85.56% | 85.56% | 838.77% | 98.07% |
|
|
|||||
| Total Current Assets | 909.12% | 85.56% | 85.56% | 838.77% | 98.07% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -3.41% | 74.41% | 74.41% | 94.94% | 4.73% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 701.16% | 89.07% | 89.07% | 661.09% | 86.00% |
|
|
|||||
| Total Accounts Payable | -81.48% | -59.78% | -59.78% | -54.01% | 27.12% |
| Total Accrued Expenses | 692.68% | 139.21% | 139.21% | -8.56% | -45.30% |
| Short-term Debt | -- | -99.17% | -99.17% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -90.70% | -87.23% | -87.23% | -49.56% | 343.62% |
|
|
|||||
| Total Current Liabilities | -90.70% | -87.23% | -87.23% | -49.56% | 343.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -99.17% | -99.17% | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -90.98% | -87.72% | -87.72% | -77.47% | 361.21% |
|
|
|||||
| Common Stock & APIC | 75.08% | 59.92% | 59.92% | 78.99% | 0.95% |
| Retained Earnings | -27.05% | -26.73% | -26.73% | -49.28% | -26.58% |
| Treasury Stock & Other | 682.57% | 652.55% | 652.55% | 740.88% | -0.27% |
| Total Common Equity | 186.15% | 172.72% | 172.72% | 205.73% | -1,498.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 186.15% | 172.72% | 172.72% | 205.73% | -1,498.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 186.15% | 172.72% | 172.72% | 205.73% | -1,498.58% |
|
|
|||||